{
    "clinical_study": {
        "@rank": "112627", 
        "brief_summary": {
            "textblock": "The aim of this prospective single-center study is to evaluate sympathetic nervous system\n      directly measured by microneurography, 24-hour blood pressure, endothelial function,\n      vascular compliance, quality of life and platelet adhesion in patients with sleep apnea\n      syndrome (defined by a complaint of excessive daytime sleepiness, an Epworth sleepiness\n      score>8[10], and an apnea/hypopnea index  (AHI>15/h) before and after catheter-based\n      radiofrequency ablation of renal nerve. If the selected patients are treated with CPAP, this\n      therapy should be stable during the whole study time. Primary and secondary end-point will\n      be measured before and 1, 3, 6 and 12 months after renal sympathetic denervation."
        }, 
        "brief_title": "Effect of Catheter-based Radiofrequency Ablation Therapy in Patient With Therapy-resistant Hypertension and Sleep Apnea Syndrome", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Therapy-resistant Hypertension and Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Hypertension", 
                "Sleep Apnea Syndromes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria: We plan to include male or female subjects, age 18-80 with a diagnosis\n        of medium-severe sleep apnea syndrome (defined by symptoms, a complaint of excessive\n        daytime sleepiness, an Epworth sleepiness score >8, and an apnea / hypopnea index >15/h)\n        and a resistant hypertension (systolic blood pressure >140 mmHg or >130 mmHg in patients\n        with type II diabetes or chronic kidney disease, under treatment with three\n        antihypertensive drugs including a diuretic).\n\n        If the selected patients are treated with CPAP, this therapy should be stable during the\n        whole study time.\n\n        Every patient will be asked for a written informed consent.\n\n        Exclusion criteria: - Heart failure (normal ejection fractions on echocardiography and no\n        clinical signs and symptoms of heart failure).\n\n          -  Long acting nitrates, or PDE-5-Hemmer\n\n          -  Alcohol or drug abuse,\n\n          -  Malignancy (unless healed or remission > 5 years)\n\n          -  Disease with systemic inflammation (e.g. rheumatoid arthritis, M. Crohn)\n\n          -  Pulmonary Hypertension (PAP>50 mmHg)\n\n          -  Pregnancy\n\n          -  Anatomical contraindication to renal denervation\n\n          -  Know allergy to contrast\n\n          -  Participation in another study within the last month"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients with therapy-resistant arterial hypertension and sleep apnea syndrome"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01879566", 
            "org_study_id": "EK2012_0393"
        }, 
        "intervention": {
            "intervention_name": "No intervention will be done. The study is observational", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Division of Cardiology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effect of Catheter-based Radiofrequency Ablation Therapy of the Renal Sympathetic-Nerve System for Patient With Sleep Apnea Syndrome and Therapy Resistant Hypertension", 
        "overall_contact": {
            "email": "isabella.sudano@usz.ch", 
            "last_name": "Isabella Sudano, MD"
        }, 
        "overall_contact_backup": {
            "email": "thomas.luescher@usz.ch", 
            "last_name": "Thomas Luescher, Prof MD"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Division of Cardiology", 
            "last_name": "Thomas Luescher, Professor, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary objective of this study is to evaluate sympathetic nervous system activity in patients with sleep apnea syndrome before and 6 and 12 months after catheter-based radiofrequency ablation therapy of the renal sympathetic-nerve system", 
            "measure": "Change in sympathetic nervous system activity (burst/min and burst/100 HB) before and after catheter-based radiofrequency ablation", 
            "safety_issue": "No", 
            "time_frame": "6 and 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01879566"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Change in 24-hour blood pressure (24 hour, day and night mean) before and after catheter-based renal denervation", 
                "measure": "Change in 24-hour blood pressure (24 hour, day and night mean) before and after catheter-based renal denervation", 
                "safety_issue": "No", 
                "time_frame": "1, 3, 6 12 months"
            }, 
            {
                "description": "Change in creatinin plasma level and GFR CKD-EPI Formula before and after catheter-based renal denervation", 
                "measure": "Change in renal function (creatinin plasma level and GFR CKD-EPI Formula) before and after catheter-based renal denervation", 
                "safety_issue": "Yes", 
                "time_frame": "1, 3, 6, 12"
            }, 
            {
                "measure": "Change in sleep quality, pulse-oximetry, AHI, quality of life and subjective sleepiness with the Epworth sleepiness score before after catheter-based renal denervation", 
                "safety_issue": "No", 
                "time_frame": "1, 3, 6 and 12 months"
            }, 
            {
                "measure": "Change in 24-hour Holter and heart rate variability, echocardiogramm before and after catheter-based renal denervation", 
                "safety_issue": "No", 
                "time_frame": "6 and 12 months"
            }, 
            {
                "description": "Change in vascular function (endothelial function as flow mediated dilatation, arterial stiffness by pulse wave velocity) and oxidative stress and inflammation parameters before and after catheter-based renal denervation", 
                "measure": "Change in vascular function and oxidative stress and inflammation parameters before and after catheter-based renal denervation", 
                "safety_issue": "No", 
                "time_frame": "1, 3, 6, and 12 months"
            }
        ], 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}